KIF1A Archives - Patient Worthy

Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder

Post author:James Moore
Post published:August 7, 2020
Post category:KIF1A Mutation Rare Disease
Post comments:0 Comments

According to a story from GlobeNewswire, the biopharmaceutical company Ovid Therapeutics Inc. and Columbia University have recently entered a collaborative partnership that will be focused on developing gene-based treatments for…

KIF1A.ORG’s KIF1A Family & Scientific Conference

Post author:James Moore
Post published:August 16, 2019
Post category:
Post comments:0 Comments

The KIF1A Family & Scientific Conference KIF1A.ORG is putting together its very first KIF1A focused family and science conference. This conference will be an unprecedented opportunity for KIF1A associated neurological…

Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder

KIF1A.ORG’s KIF1A Family & Scientific Conference

Make a difference, share your experiences and get paid. Opt-in & join Patient Worthy’s panel for paid opportunities such as Surveys, Market Research, Patient Advisory Panels & much more.

Let’s Work Together!

Keep Up to Date

Learn More

SIGN UP FOR OUR NEWSLETTER
Email Address